Anixa Biosciences ANIX shares gained 13% on Wednesday following the announcement that the U.S. Patent and Trademark Office ...

Anixa Biosciences, Inc.’s ANIX share price has surged by 7.56%, which has investors questioning if this is right time to sell ...

On Wednesday, the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for a new patent related to ...

Fintel reports that on March 21, 2025, Maxim Group initiated coverage of Anixa Biosciences (NasdaqCM:ANIX) with a Buy recommendation. Analyst Price Forecast Suggests 175.24% Upside As of March 19, ...

SAN JOSE, Calif., April 9, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer ...

SAN JOSE, Calif., March 17, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer ...

Maxim initiated coverage of Anixa Biosciences (ANIX) with a Buy rating and $10 price target Light Up your Portfolio with Spark:Easily identify ...

Explore Anixa Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ANIX. EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...